leisure time -WSS

leisure time

author：fashion 2025-09-14 08:26:27 - browse：5

Pfizer on Friday said it was stopping development of a twice-daily oral obesity medication after an underwhelming clinical trial, a blow to the company’s efforts to compete in the booming field of weight-loss medications.

The medicine, danuglipron, met its primary target in a placebo-controlled Phase 2b trial, leading to a statistically significant amount of weight lost, the company said. But the weight reductions were smaller than those seen in trials of rival medicines targeting the same GLP-1 pathway, and a high rate of patients experienced side effects and dropped out of the trial.

Pfizer said it would not move twice-daily danuglipron into Phase 3 trials, but that instead it would focus on a once-daily formulation, which is currently undergoing pharmacokinetic studies. Data are expected in the first half of 2024.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Will biotech layoffs continue through 2023?

WSS

Biden declares emergency in flood

Wisconsin governor employs partial veto to fund schools for 4 centuries

Trader Joe's recalls 10K cases of broccoli cheddar soup over potential foreign material

Alexander Hamilton and the argument for universal insurance

The mammogram wars are not over

Ford recalls 870K F

Wikipedia

leisure time

Wikipedia

What does generative AI mean for health care? We asked experts

Stoke drug shows lower activity against childhood epilepsy

In age of alternative facts, a scholarly course on calling out crap

Rikers Island jail violence not addressed, NYC should be held in contempt: Fed monitor

Walensky prepares to leave CDC — and Congress — behind

Interest rates are at a 22

Tori Bowie and the unacceptable rates of Black maternal death

Biden’s NIH nominee is languishing in Congress

Anesthesiologist group: stop taking Ozempic before surgery

The U.S. needs a new definition of substance use “recovery”

Wikipedia

Rikers Island jail violence not addressed, NYC should be held in contempt: Fed monitor

Recent heat wave in the Mediterranean caused by climate change: Study

As the dark side of IVF slowly comes into focus, even more transparency is needed

Pandemic and All Hazards Preparedness Act needs lean update

An outrageous hospital charge: I paid $710 for an hour of babysitting

White House announces new plan to address the growing threat of xylazine in overdose crisis

knowledge

explore

focus

focus